Customize Your Learning Experience!

Mix-and-match sessions from these additional co-located conferences at no additional cost:

• Process & Product Validation
• Technology Transfer for Biopharmaceuticals
• Outsourcing Manufacturing of Biopharmaceuticals
• Viral Safety for Biologicals

Stay for the week so you can attend on Feb. 29 - March 2 for these conferences:

• Antibody Development & Production
• Recombinant Protein & Complex Biologic Development & Production
• Analytical Technologies for Biotherapeutic Development
• Biobetters & Biosimilars: Technologies & Development Strategies

Get the Most Out of Your Budget with the "All Access Pass" to Attend Sessions from All 9 Conferences

View the Agenda-at-a-Glance for the Entire Week.

Special Discounted Hotel Rate

Special Discounted Hotel Rate Available Until February 3, 2012.
To book your room, call 1-800-HILTONS and mention that you are an IBC attendee at this event.

Get Up To Date Event Information

Join our priority contact list and receive the latest event news.

As process characterization and process understanding methods have advanced, it has become statistically apparent that raw materials can be a major source of variability, affecting development and manufacturing.

Attend this conference to learn about:

• Strategies to develop a comprehensive raw material variability testing, characterization and control plan
• Risk-mitigation in media/feed change, hydrolysates and other upstream operations
• Chromatography resins, adsorbent lot variability and other downstream challenges
• Developing a raw material control strategy for use at multiple manufacturing sites
• Mitigating risk of raw material contamination by adventitious agents
• Strategies to ensure safety and reliability of supplier-derived raw materials

Featured Presentations

Development of a Raw Material Control Strategy for Use at Multiple Manufacturing Sites
Matt Osborne, Ph.D.
Cell Culture Technical Lead
Eli Lilly S.A., Ireland

Quality Management Best Practices in the Raw Material Supply Chain
Kimberly Carnes
Manager, Quality Assurance Compliance
Human Genome Sciences, Inc.

Strategies to Reduce Production Disturbances and Performance Variability Introduced by Raw Materials used in Product Manufacturing Operations
Victor J. Melendez Colon, Ph.D.
Principal Scientist, Process Development
Amgen Manufacturing, Limited, Puerto Rico

Assessment of Variability in Upstream Media and Feed Change and its Impact on Antibody Cell Line Performance and Quality Attributes
Abdul Wajid, Ph.D.
Senior Director, Process Sciences
XOMA (US) LLC